Anti-inflammatory therapies for cystic fibrosis-related lung disease. - Wikidata - awgldk - TriplyDB

Anti-inflammatory therapies for cystic fibrosis-related lung disease.

Anti-inflammatory therapies for cystic fibrosis-related lung disease.

http://www.wikidata.org/entity/Q37188760

about

Pharmacological correction of a defect in PPAR-gamma signaling ameliorates disease severity in Cftr-deficient mice.Bergamot (Citrus bergamia Risso) fruit extracts and identified components alter expression of interleukin 8 gene in cystic fibrosis bronchial epithelial cell lines.Regulation of ENaC-Mediated Sodium Reabsorption by Peroxisome Proliferator-Activated Receptors Autophagy enhances bacterial clearance during P. aeruginosa lung infection.Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment.Anchored PDE4 regulates chloride conductance in wild-type and ΔF508-CFTR human airway epithelia.Update in cystic fibrosis 2010.Cell therapy for cystic fibrosis.Considerations for the Conduct of Clinical Trials with Antiinflammatory Agents in Cystic Fibrosis. A Cystic Fibrosis Foundation Workshop Report.Ibuprofen regulation of microtubule dynamics in cystic fibrosis epithelial cells.Phospholipase C-β3 is a key modulator of IL-8 expression in cystic fibrosis bronchial epithelial cells.The immunomodulatory effect of inhaled granulocyte-macrophage colony-stimulating factor in cystic fibrosis. A new treatment paradigm.Macrophage Dysfunction in Cystic Fibrosis: A Therapeutic Target to Enhance Self-Immunity.Antimicrobial Activity of Ibuprofen Against Cystic Fibrosis Associated Gram-Negative Pathogens.

P2860

Q33712428-B8638FAF-5220-43B0-973A-0AF7399879C4 Q33874258-81EC3ADC-5BB7-4038-A861-23D61D78348B Q33960919-1F4D2F3E-3118-4F0F-831E-9E3C30C66231 Q34981436-65BBEDAF-2416-4654-A8DB-4538AE60CF62 Q36559330-DE80DA74-D9C7-4E73-A7FB-9B80066F070B Q37503665-3F7712A4-74C4-45F3-95DC-F9F735379DF5 Q37892766-63C899B3-419F-440B-BA56-A846C82A7304 Q38124849-9D79C307-1BC3-468B-A8A8-7E19E11B5E4D Q38543069-D3D32B13-7B9B-4AA9-B98D-A45E79EE33A9 Q38763646-5EFC6D1D-ADDA-4F10-8ECD-FE7D076EE631 Q39575146-618DEF1F-CFD8-493B-91C6-5E40244D5895 Q39652354-4FD2B3D6-D772-4560-AD1E-D674627AE26F Q48088208-DE508D91-2A20-42E5-9F5A-E832A96EA2CC Q50134125-BFE9CEFD-A08D-45D0-BD97-154E3D129754

P2860

Anti-inflammatory therapies for cystic fibrosis-related lung disease.

http://www.wikidata.org/entity/Q37188760

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Anti-inflammatory therapies for cystic fibrosis-related lung disease.

@en

Anti-inflammatory therapies for cystic fibrosis-related lung disease.

@nl

type

label

Anti-inflammatory therapies for cystic fibrosis-related lung disease.

@en

Anti-inflammatory therapies for cystic fibrosis-related lung disease.

@nl

prefLabel

Anti-inflammatory therapies for cystic fibrosis-related lung disease.

@en

Anti-inflammatory therapies for cystic fibrosis-related lung disease.

@nl

P1433

Q37188760-C874298B-2240-4B47-B4D2-EAB987F8386C

P1476

Q37188760-73B7BC72-570A-48F6-8911-49550A406D23

P2093

Q37188760-0E78DDCE-31E7-49C1-974E-80D3BCADFF58

Q37188760-864FA2FB-D181-4087-A28C-2205FA432BDB

Q37188760-95C68F6A-247C-4441-AA5B-CE63D77766B4

P2860

Q37188760-11AC2535-4E6F-4C4D-A7A6-EDC0D6784508

Q37188760-2CBF8B7F-7CBA-40C8-AEAB-1F05CF9079FB

Q37188760-3AF1B746-6DAA-48EC-B1B9-F1E58713F200

Q37188760-55A4C815-B9B6-4C54-8703-DE01B52E2E86

Q37188760-65EA22BC-356C-4749-AED2-3B06C139CDA5

Q37188760-7328B820-AD99-47EB-8E6B-55C04AD0696B

Q37188760-7E4A19C4-A73A-4692-8BFE-3859326F207C

Q37188760-7F264FB5-10B1-4335-8583-3D0EF3C7403F

Q37188760-9740F51D-6D7D-4E97-B18C-8FD7BFD8A3D9

Q37188760-B67929F6-6253-4939-826C-74218FA32C1E

P2888

Q37188760-B1361C3F-EF93-4B00-BF95-A1E01718A94F

P304

Q37188760-211E55EF-BA04-4E1D-9ED7-C5C660936595

P31

Q37188760-E61C6098-CA0B-4EAC-9025-2C719EF21EFF

P356

Q37188760-224C5D0F-A5A9-4752-812E-7764476AE78F

P433

Q37188760-F933BB7A-6329-4075-873B-8FC2C89B12B0

P478

Q37188760-A46FF039-C819-47B3-8F77-DF0E8A2D2DC4

P577

Q37188760-4333D1B2-F37F-44D2-B56F-A06D1CA0123E

P5875

Q37188760-C67A99B9-722E-4785-B0FA-E6BCFE10A5AD

P698

Q37188760-B3EC7474-656D-4EC1-8394-494D847150CA

P921

Q37188760-67A3641D-C682-4A8E-A0CC-3AFB417FB1FC

Q37188760-83B16CAA-DBEA-418A-AA80-1982B955128D

P356

S12016-008-8081-2

P1433

Clinical Reviews in Allergy & Immunology

P1476

Anti-inflammatory therapies for cystic fibrosis-related lung disease.

@en

P2093

David P Nichols

http://www.w3.org/2001/XMLSchema#string

James F Chmiel

http://www.w3.org/2001/XMLSchema#string

Michael W Konstan

http://www.w3.org/2001/XMLSchema#string

P2860

Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis

Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis.

Statin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells.

Signaling intermediates required for NF-kappa B activation and IL-8 expression in CF bronchial epithelial cells.

Mechanisms of NOS2 regulation by Rho GTPase signaling in airway epithelial cells.

Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells.

Cystic fibrosis transmembrane conductance regulator-dependent regulation of epithelial inducible nitric oxide synthase expression.

Protection against acute lung injury by intravenous or intratracheal pretreatment with EPI-HNE-4, a new potent neutrophil elastase inhibitor.

Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection. Implications for antiinflammatory therapy in cystic fibrosis.

Characterization of LPS-induced lung inflammation in cftr-/- mice and the effect of docosahexaenoic acid.

P2888

s12016-008-8081-2

P304

135-153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12016-008-8081-2

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5311384

http://www.w3.org/2001/XMLSchema#string

P698

18546078

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis